Literature DB >> 30026893

Combined Approach to Treat Medication-Related Osteonecrosis of the Jaws.

Elisabetta Merigo1,2, Luigi Cella2, Aldo Oppici2, Maria Cristina Arbasi3, Fabio Clini2, Matteo Fontana2, Carlo Fornaini1,2.   

Abstract

Introduction: The proper therapeutic plan for medication-related osteonecrosis of the Jaw (MRONJ) is still lacking long-term data up to today. They were several high-technological appliances proposed for the different intervention steps, in addition to tissue repair promoters. The reason for proposing an integrated technique is justified, beyond better compliance of the patients associated to the pain and inflammation reduction and bleeding control, there is also achieving better hard and soft tissues healing.
Methods: Patients diagnosed with bisphosphonates-related osteonecrosis of the jaws (BRONJ) at the Odontostomatology and Maxillo-Facial Surgery Unit of the Hospital of Piacenza undergone surgical intervention. The intervention was performed by using different devices: Piezosurgery for removing the necrotic bone tissue and for obtaining the bone specimen essential for histological analysis; Er:YAG laser (2940 nm) to vaporize necrotic hard tissue until reaching the bleeding bone; platelet-rich plasma (PRP) to stimulate hard and soft tissue healing; and finally diode laser (808 nm) to perform a biostimulation of the surgical site.
Results: All treated patients demonstrated a good postoperative comfort even without using painkillers, no bleeding, and a fast healing process. Most of the patients (92.85%) reached complete healing with a minimum follow up at 6 months. Histological exams demonstrated a good quality without artifacts.
Conclusion: Sequential utilization of different high-technologies devices during all the steps of MRONJ treatment allows to perform a faster and less invasive surgery with a more comfortable postoperative healing process and it may represent a new and original approach for treating this severe adverse event.

Entities:  

Keywords:  BRONJ; Laser; Medication-related osteonecrosis of the jaws; Piezosurgery; Platelet-rich factor

Year:  2018        PMID: 30026893      PMCID: PMC6046388          DOI: 10.15171/jlms.2018.19

Source DB:  PubMed          Journal:  J Lasers Med Sci        ISSN: 2008-9783


  54 in total

1.  Early surgical laser-assisted management of bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 101 treated sites with long-term follow-up.

Authors:  Paolo Vescovi; Maddalena Manfredi; Elisabetta Merigo; Rebecca Guidotti; Marco Meleti; Giuseppe Pedrazzi; Carlo Fornaini; Mauro Bonanini; Teore Ferri; Samir Nammour
Journal:  Photomed Laser Surg       Date:  2011-11-04       Impact factor: 2.796

Review 2.  Piezosurgery in oral and maxillofacial surgery.

Authors:  G Pavlíková; R Foltán; M Horká; T Hanzelka; H Borunská; J Sedý
Journal:  Int J Oral Maxillofac Surg       Date:  2010-12-19       Impact factor: 2.789

Review 3.  Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients.

Authors:  Paolo Vescovi; Elisabetta Merigo; Marco Meleti; Maddalena Manfredi; Rebecca Guidotti; Samir Nammour
Journal:  J Oral Pathol Med       Date:  2011-09-30       Impact factor: 4.253

Review 4.  Management of Medication-Related Osteonecrosis of the Jaw.

Authors:  William Bradford Williams; Felice O'Ryan
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2015-11       Impact factor: 2.802

5.  Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease.

Authors:  R E Marx; R Tursun
Journal:  Int J Oral Maxillofac Surg       Date:  2012-01-11       Impact factor: 2.789

6.  Comparison of the low level laser therapy effects on cultured human gingival fibroblasts proliferation using different irradiance and same fluence.

Authors:  L Almeida-Lopes; J Rigau; R A Zângaro; J Guidugli-Neto; M M Jaeger
Journal:  Lasers Surg Med       Date:  2001       Impact factor: 4.025

7.  Use of Ultrasonic Bone Surgery (Piezosurgery) to Surgically Treat Bisphosphonate-Related Osteonecrosis of the Jaws (BRONJ). A Case Series Report with at Least 1 Year of Follow-Up.

Authors:  Cornelio Blus; Serge Szmukler-Moncler; Giulio Giannelli; Gloria Denotti; Germano Orrù
Journal:  Open Dent J       Date:  2013-08-23

8.  Effects of 3 years treatment with once-yearly zoledronic acid on the kinetics of bone matrix maturation in osteoporotic patients.

Authors:  S Gamsjaeger; B Hofstetter; E Zwettler; R Recker; J A Gasser; E F Eriksen; K Klaushofer; E P Paschalis
Journal:  Osteoporos Int       Date:  2012-11-15       Impact factor: 4.507

9.  Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management.

Authors:  Lucio Montebugnoli; Laura Felicetti; Davide Bartolomeo Gissi; Angelo Pizzigallo; Gian Andrea Pelliccioni; Claudio Marchetti
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2007-05-07

10.  Conservative surgical management of stage I bisphosphonate-related osteonecrosis of the jaw.

Authors:  Paolo Vescovi; Elisabetta Merigo; Marco Meleti; Maddalena Manfredi; Carlo Fornaini; Samir Nammour; Giovanni Mergoni; Amin Sarraj; Jose V Bagan
Journal:  Int J Dent       Date:  2014-02-06
View more
  5 in total

1.  Retrospective Analysis of Treatment Outcomes of Maxillary Sinusitis Associated with Medication-Related Osteonecrosis of the Jaw.

Authors:  Mitsunobu Otsuru; Saki Hayashida; Kota Morishita; Maho Murata; Sakiko Soutome; Miho Sasaki; Yukinori Takagi; Misa Sumi; Masahiro Umeda
Journal:  Int J Environ Res Public Health       Date:  2022-06-17       Impact factor: 4.614

2.  Therapeutic Approach in the Treatment of Medication-Related Osteonecrosis of the Jaw: Case Series of 3 Patients and State of the Art on Surgical Strategies.

Authors:  Erica Vettori; Giulia Pipinato; Rossana Bussani; Fulvia Costantinides; Vanessa Nicolin; Lorenzo Bevilacqua; Michele Maglione
Journal:  J Oral Maxillofac Res       Date:  2021-06-30

3.  Factors Exacerbating Clinical Symptoms and CT Findings in Patients with Medication-Related Osteonecrosis of the Jaw Receiving Conservative Therapy: A Multicenter Retrospective Study of 53 Cases.

Authors:  Yuka Kojima; Sakiko Soutome; Mitsunobu Otsuru; Saki Hayashida; Yuki Sakamoto; Shunsuke Sawada; Masahiro Umeda
Journal:  Int J Environ Res Public Health       Date:  2022-06-26       Impact factor: 4.614

4.  Complementarity of surgical therapy, photobiomodulation, A-PRF and L-PRF for management of medication-related osteonecrosis of the jaw (MRONJ): an animal study.

Authors:  Mohammad Reza Jamalpour; Shiva Shahabi; Mehdi Baghestani; Abbas Shokri; Shokoofeh Jamshidi; Salman Khazaei
Journal:  BMC Oral Health       Date:  2022-06-18       Impact factor: 3.747

5.  Combined approach to treatment of advanced stages of medication-related osteonecrosis of the jaw patients.

Authors:  Onur Şahin; Ender Akan; Birkan Tatar; Ceren Ekmekcioğlu; Nuri Ünal; Onur Odabaşı
Journal:  Braz J Otorhinolaryngol       Date:  2021-05-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.